Form 4: UNH Director Timothy Flynn Acquires Shares

UnitedHealth Group Director Timothy Flynn reported the acquisition of 65 common shares as dividend equivalents on vested deferred stock units.

Summary

• Timothy Patrick Flynn, a Director at UnitedHealth Group Inc. (UNH), acquired 65 shares of common stock.
• The acquisition occurred on December 16, 2025, and was reported on December 18, 2025.
• These shares were received as dividend equivalents on vested deferred stock units, with a transaction price of $0.
• Following this transaction, Flynn directly owns 9,875 common shares and indirectly owns 6,033 common shares through a trust.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading schedule.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if through dividend equivalents, increases their beneficial ownership in the company, which can be seen as a positive signal of alignment with shareholder interests. The transaction is routine and part of an existing equity compensation plan.

Positives

• Director Timothy Flynn increased his beneficial ownership in UnitedHealth Group by 65 shares.
• The acquisition represents dividend equivalents paid on vested deferred stock units, indicating ongoing benefits from existing equity holdings and alignment with shareholder interests.

Future Outlook

NA

Industry Context

NA

Corporate Governance

Related Party Transactions

• Acquisition of 65 common shares by Director Timothy P. Flynn from UnitedHealth Group Inc. as dividend equivalents on vested deferred stock units.

Stakeholder Impact

• Shareholders: Increased insider ownership, potentially signaling continued confidence in the company's long-term prospects and aligning management interests with shareholder value.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a director through dividend equivalents on vested deferred stock units, executed under a Rule 10b5-1(c) plan. While it slightly increases insider ownership, it does not represent a discretionary open market purchase or a significant change in the company's fundamental outlook or valuation that would warrant a 'buy' or 'sell' recommendation. It's a standard compensation-related event and does not provide new material information to alter an existing investment thesis.

Keywords

UnitedHealth Group, UNH, Timothy Flynn, Director, Insider Transaction, Form 4, Stock Acquisition, Dividend Equivalents, Deferred Stock Units, Corporate Governance